These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2884121)

  • 21. Sexual excitement and stretching and yawning induced by B-HT 920.
    Ferrari F
    Pharmacol Res Commun; 1985 Jun; 17(6):557-64. PubMed ID: 2862647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of K+-stimulated [3H]dopamine and [14C]acetylcholine release by the putative dopamine autoreceptor agonist, B-HT 920.
    Schmidt CJ; Lobur A; Lovenberg W
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):377-82. PubMed ID: 2434870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-HT 958--an antagonist at alpha 2-adrenoceptors and an agonist at dopamine autoreceptors in the brain.
    Hörtnagl H; Pichler L; Holzer-Petsche U; Hornykiewicz O; Kobinger W
    Eur J Pharmacol; 1984 Nov; 106(2):335-44. PubMed ID: 6152218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the D2-autoreceptor agonist B-HT 958 on both spontaneous and ACTH-induced stretching, yawning and grooming in the rat.
    Ferrari F; Pelloni F; Filaferro M; Giuliani D
    Life Sci; 1992; 50(14):1013-9. PubMed ID: 1348099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J; Briley M; Langer SZ
    Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The alpha 2-adrenoceptor antagonists idazoxan and yohimbine can unmask the postsynaptic dopamine agonist effects of B-HT 920.
    Meltzer LT; Wiley JN; Heffner TG
    Eur J Pharmacol; 1989 Oct; 170(1-2):105-7. PubMed ID: 2575523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of motor activity by alpha 1- and alpha 2-adrenoceptor stimulation in mice.
    Pichler L; Kobinger W
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):180-2. PubMed ID: 6117802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons.
    Ackerman JM; Johansen PA; Clark D; White FJ
    J Pharmacol Exp Ther; 1993 May; 265(2):963-70. PubMed ID: 8098768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain.
    Andén NE; Nilsson H; Ros E; Thornström U
    Acta Pharmacol Toxicol (Copenh); 1983 Jan; 52(1):51-6. PubMed ID: 6301216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice.
    Verma A; Kulkarni SK
    Indian J Exp Biol; 1991 Feb; 29(2):123-6. PubMed ID: 1831182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of idazoxan on the dopamine D2 receptor agonist-induced behavioural effects in rats.
    Ferrari F; Giuliani D
    Eur J Pharmacol; 1993 Nov; 250(1):51-7. PubMed ID: 7907024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
    Kohno Y; Fukuzaki K; Kitahara K; Koja T
    Eur J Pharmacol; 1997 Jan; 319(2-3):197-205. PubMed ID: 9042591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased motor activity following combined stimulation of B-HT 920-sensitive and D-1 dopamine receptors.
    Andén NE; Grabowska-Andén M
    Acta Physiol Scand; 1987 Sep; 131(1):157-8. PubMed ID: 2890261
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis.
    Jovanović-Mićić D; Samardzić R; Beleslin DB
    Eur J Pharmacol; 1995 Jan; 272(1):21-30. PubMed ID: 7713146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-HT 920 antagonizes rat neophobia in the X-maze test: a comparative study with other drugs active on adrenergic and dopaminergic receptors.
    Ferrari F; Tartoni PL; Mangiafico V
    Arch Int Pharmacodyn Ther; 1989; 298():7-14. PubMed ID: 2569300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of B-HT 920 and St 91 on venous haemodynamics in cats.
    Widdop RE
    J Pharm Pharmacol; 1989 Jan; 41(1):55-6. PubMed ID: 2565967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emetic effect of B-HT 920 and apomorphine in the dog: antagonism by haloperidol.
    Hsu WH; Schaffer DD; Dyer DC
    Life Sci; 1986 Sep; 39(11):1021-6. PubMed ID: 2875373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay.
    Preziosi P; Martire M; Navarra P; Pistritto G; Vacca M
    J Pharmacol Exp Ther; 1989 Apr; 249(1):256-63. PubMed ID: 2565391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
    Devoto P; Flore G; Pani L; Gessa GL
    Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unmasking of the inhibitory action of glucose on insulin release after alpha 2-adrenergic activation.
    Bergsten P; Hellman B
    Biochem Biophys Res Commun; 1986 Sep; 139(2):557-63. PubMed ID: 2876704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.